FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1564191000168109: cannabidiol 100 mg / 1 mL + delta-9-tetrahydrocannabinol 3 mg / 1 mL oral liquid, 30 mL (medicinal product pack)

Status: current, Defined. Date: 31-Aug 2021. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4605531000168119 cannabidiol 100 mg / 1 mL + delta-9-tetrahydrocannabinol 3 mg / 1 mL oral liquid, 30 mL (medicinal product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4605541000168111 delta-9-tetrahydrocannabinol 3 mg/mL + cannabidiol 100 mg/mL oral liquid, 30 mL en Synonym Active Case sensitive Australian Medicines Terminology module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
delta-9-tetrahydrocannabinol 3 mg/mL + cannabidiol 100 mg/mL oral liquid, 30 mL Is a medicinal product pack false Inferred relationship Some
delta-9-tetrahydrocannabinol 3 mg/mL + cannabidiol 100 mg/mL oral liquid, 30 mL has MPUU delta-9-tetrahydrocannabinol 3 mg/mL + cannabidiol 100 mg/mL oral liquid true Inferred relationship Some 1379549344
delta-9-tetrahydrocannabinol 3 mg/mL + cannabidiol 100 mg/mL oral liquid, 30 mL Is a cannabidiol 100 mg/mL oral liquid, 30 mL true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Canndeo 1:30 (THC 3:CBD 100) oral liquid, 30 mL Is a True delta-9-tetrahydrocannabinol 3 mg/mL + cannabidiol 100 mg/mL oral liquid, 30 mL Inferred relationship Some

Reference Sets

Schedule 8 medications reference set

Medicinal product pack reference set

Back to Start